EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a HiBiT-tagged reporter Akabane virus and its application in antiviral drug screening

Tianai Zhang, Zhongyin Liu, Yao Zhao, Jiamin Qin, Shucheng Zong, Wenke Ruan, Di Wang, Dongjie Chen, Shengkui Xu

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2025.1760466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Tianai Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Traditional Chinese Veterinary Medicine, College of Animal Science and Technology, Beijing University of Agriculture, Beiji…. Hauptthemen laut MEDLINE: Antiviral Agents, Genes, Reporter, Orthobunyavirus. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Akabane virus (AKAV), an arthropod-borne pathogen causing severe reproductive failure in ruminants, poses a major threat to livestock industry. Given the lack of vaccines and antiviral drugs against AKAV, the development of rapid antiviral screening tools is urgently needed. To establish a quantifiable platform for AKAV research, we constructed a reporter virus (rAKAV-L-HiBiT) by inserting the 11-amino-acid HiBiT subunit of NanoLuc luciferase into the C-terminus of the L protein. The recombinant virus was characterized for growth kinetics, genetic stability, and luciferase activity. rAKAV-L-HiBiT exhibited a similar replication profile to wild-type AKAV and maintained stable luciferase activity over 10 passages in vitro . Crucially, luciferase activity of rAKAV-L-HiBiT showed a strong positive correlation with viral loads (r > 0.99), validating its utility as a convenient and rapid platform for AKAV quantification. Subsequently, we applied this platform to neutralization and antiviral compound screening assays and Remdesivir was identified as a potent inhibitor of AKAV. Taken together, our study presents rAKAV-L-HiBiT as a reliable tool for rapid antiviral drug discovery and neutralization testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsGenes, ReporterOrthobunyavirusAnimalsLuciferasesDrug Evaluation, PreclinicalViral LoadVirus ReplicationCell LineNeutralization Tests

Stichwörter der Autor:innen

AKAVHiBiTdrug screeningluciferase activityreporter virus

Substanzen

Antiviral AgentsLuciferases

Autor:innen und Institutionen

  • Beijing Key Laboratory of Traditional Chinese Veterinary Medicine, College of Animal Science and Technology, Beijing University of Agriculture, Beijing, China.
  • Key Laboratory of Veterinary Biological Products and Chemical Drugs, Ministry of Agriculture and Rural Affairs, Engineering and Technology Research Centre for Beijing Veterinary Peptide Vaccine Design and Preparation, Z…
  • School of Agroforestry and Medicine, The Open University of China, Beijing, China.
  • Institute of Animal Inspection and Quarantine, Chinese Academy of Quality and Inspection & Testing, Beijing, China.

Zitieren

APA

Zhang, T., Liu, Z., Zhao, Y., Qin, J., Zong, S., Ruan, W., Wang, D., Chen, D., & Xu, S. (2026). Development of a HiBiT-tagged reporter Akabane virus and its application in antiviral drug screening. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1760466

Vancouver

Zhang T, Liu Z, Zhao Y, Qin J, Zong S, Ruan W, et al. Development of a HiBiT-tagged reporter Akabane virus and its application in antiviral drug screening. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2025.1760466

BibTeX
@article{Zhang2026,
  author = {Zhang, Tianai and Liu, Zhongyin and Zhao, Yao and Qin, Jiamin and Zong, Shucheng and Ruan, Wenke and Wang, Di and Chen, Dongjie and Xu, Shengkui},
  title = {Development of a HiBiT-tagged reporter Akabane virus and its application in antiviral drug screening},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2025.1760466}
}
Kostenlos starten →